Target intelligence / Profile preview

Off-target mRNAs with partial complementarity to the EIF4G1 shRNA guide strand

Molecular classification
Messenger RNA (mRNA)
01

Overview

This entry refers to a group of unintended messenger RNA (mRNA) transcripts that are silenced during RNA interference (RNAi) experiments designed to target Eukaryotic translation initiation factor 4 gamma 1 (EIF4G1). When shRNA is used to knock down EIF4G1, the guide strand can incorporate into the RNA-induced silencing complex (RISC) and bind to other mRNAs with partial sequence complementarity, most commonly through the 'seed region' (nucleotides 2-8) in the 3' untranslated region (Jackson et al., 2003). This interaction leads to the degradation or translational inhibition of non-target genes, a phenomenon known as seed-mediated off-target effects (Birmingham et al., 2006). EIF4G1 itself is a critical scaffold protein in the eIF4F complex that facilitates the recruitment of the 40S ribosomal subunit to mRNA for protein synthesis (Sonenberg & Hinnebusch, 2009). Because EIF4G1 is frequently overexpressed in various cancers, it is a common subject of knockdown studies; however, off-target effects can confound results by inducing phenotypes, such as cell death, that are unrelated to EIF4G1 depletion (Sigoillot et al., 2012). These off-target events represent a significant technical challenge in drug discovery and functional genomics, necessitating the use of multiple independent shRNA sequences or rescue experiments to validate findings. Consequently, these mRNAs are not therapeutic targets themselves but are critical confounding factors in the development and validation of EIF4G1-targeted therapies.

Other names
RNAi off-target effectsSeed-mediated off-targetsshRNA-induced off-target transcriptsEIF4G1 shRNA off-targets
02

Mechanism of action

Unintended gene silencing via the RNA-induced silencing complex (RISC) where the shRNA guide strand binds to mRNAs with partial sequence complementarity, typically mediated by the 5' seed region (nucleotides 2-8).

03

Biological functions

Gene expression regulationTranslation
04

Disease associations

Experimental artifact
05

Safety considerations

Off-target toxicityFalse positive phenotypic resultsConfounding of experimental data in functional genomics
06

Interacting drugs

EIF4G1 shRNA (experimental reagent)

Beyond the preview

Go deeper on Off-target mRNAs with partial complementarity to the EIF4G1 shRNA guide strand.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Off-target mRNAs with partial complementarity to the EIF4G1 shRNA guide strand.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call